- High quality editing
Journal of Medical and Radiation Oncology (JMedRadOnc) is a peer reviewed journal,
and your article will significantly benefit from the careful review and suggestions of our
– Professor Dr. Gabriel Kacso is the Head of Oncology-Radiotherapy Department of
University of Medicine & Pharmacy “Iuliu Hatieganu” Cluj-Napoca, CMO and Chairman
of International Scientific Board Amethyst Europe, past President of the Romanian
Society of Radiotherapy and Medical Oncology, and Medical Director of Amethyst
– Dr. Mircea Dediu, Chief of Medical Oncology at Sanador Clinic in Bucharest has a
vast experience in Medical Oncology and has been involved for more than two decades
in dozens of clinical trials and has summarized the advancements in the field of oncology
at more than one hundred conferences.
– Professor Dr. Ioana Berindan-Neagoe is the Scientific Director of Research Center
for Functional Genomics, Biomedicine and Translational Medicine and Research Center
in Advanced Medicine – Medfuture. She received the Ad Astra Prize in 2018 for the best
scientist in Romania in Life Sciences. During the last ten years, she coordinated more
than fifty research projects and she published more than three hundred scientific papers.
– Professor Dr. Ștefana Petrescu is the Director of the Biochemistry Institute in
Bucharest. She has been granted the Emil Racoviță Award of the Romanian Academy
for her work on tyrosinase folding in 2002. She has been the President of the Romanian
Society of Biochemistry and Molecular Biology since 2010. She is also the Deputy-Editor
of Molecular Life.
– Professor Diana Ionescu is a Clinical Professor of Pathology at the University of
British Columbia, Medical Lead of Anatomic Pathology at BC Cancer in Vancouver, BC,
and served as the residency program director for the Anatomic Pathology Residency
Program. She is also the Canadian Anatomic and Molecular Pathology (CAMP) and
Pathology-Oncology Digital Series (CAMP-PODS) course director. She is recognized as
one of the two main leading lung cancer pathologists in Canada.
– Dr. Gabriela Gheorghe is an Associate Professor of Pathology at St. Jude, the
leading hospital for pediatric hematological malignancies in the US. She has been in
practice for more than twenty years and has a particular interest in Molecular Pathology
- Find a niche for your research
Our journal provides a broad coverage from basic and translational research to clinical
research including all types of hematologic malignancies and solid tumors. Therefore,
the potential number of topics is unlimited and, if your data is solid and your ideas are
well presented, we guarantee the publication of your article in our journal.
- Sharpen your ideas
Committing your thoughts to paper will help you clarify them and, hopefully, advance
your present and future research. Our editors and reviewers’ feedback may assist you to
develop your arguments in the most effective ways, and, sometimes, you may benefit
from a fresh and objective perspective of your work.
- Advance the area of your research
Communicating your findings and ideas to a broad audience, will both help your
colleagues and will contribute to advancing knowledge in the oncology area or subject of
interest to you.
- Introduce novel frames
Publishing your research may stimulate new understanding of biological processes, in
general, and, malignant conditions, in particular. Overall, in the long run, your discoveries
may improve the quality and duration of life of cancer patients.
Describing your ideas and data in a clear and concise manner may help you put your
research into a larger context and, at the same time, help you to better define your future
- Stay up-to-date
The field of oncology changes extremely fast and it is important to stay up-to-date with
the latest developments. In the process of writing an article, you may find out about recent
advances that you may have not been aware of before. The prewriting research may also
prevent duplication of efforts, both by you, through discovering other’s work, and by
others, through discovering your work.
- Increase your visibility
Publishing in a peer reviewed international journal will give your work and ideas visibility
among your peers and other researchers in your field. It can also highlight key issues,
important both to the academia and to the general public such as the Covid-19 epidemic,
for example, which has been attracting a lot of attention in the last two years.
- Grow academically
We are working hard towards indexing JMedRadOnc in PubMed and other databases
and this will also benefit your future academic career. On your applications for academic
appointments and promotions, as well as on grant applications, you may be required to
list your publications in accredited journals, and, starting this process in an open access
journal, is a plus. Also, down the road, after your study is completed, you may be required
by funding agencies to publish your work in certain journals, as open access, and you
can publish it with us.
- Publish with no fees
Last but not the least, compared to many oncology journals available today,
JMedRadOnc does not charge any publication or processing fee. The journal also
provides free English editing if your article is accepted for publication.
We welcome your suggestions, comments and, of course, your articles.
Happy New Year and all the best in 2022!
Doru Paul, MD, PhD